speb/financial-data huggingface dataset:
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 16311000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 151800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 18083700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Net Income: -333800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -333800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -333800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -333800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -333800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -333800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -257200000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -257200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 30205700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 15323100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 483800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 47400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Normalized Income: -333800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Operating Income: -264400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 4453700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 118656160.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1413100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 67700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 15205300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 206300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 426200000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 83900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 835600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 12807400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 1817700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Payables: 3770300000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Pretax Income: -437700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 3414900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 227900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 118656160.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 15324000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 15323100000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Tax Provision: -103900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 109900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 43445400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 30881100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 20856200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 15324000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 4718100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 28121400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 32507900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 18741100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 1557200000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1153900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 4158500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 118801020.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: -3.92
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 3382000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 226500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 226500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 118801020.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: -3.92
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -465700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — EBIT: -337700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — EBITDA: -111200000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 776500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 214900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 214900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Net Income: -465700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -465700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -465700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -465700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -465700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -465700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -214900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -214900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -111200000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -465700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Operating Income: -377400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 4158500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 39700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 731200000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -552600000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 3382000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 226500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: -86900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.16
TIRUMALCHM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 4535900000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 4452000000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1179600000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 17218600000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 4242500000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 2870700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2870700000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1970000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1970000000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -4851300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -4851300000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 5133800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 5133800000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -55000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -55000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Amortization: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 1542200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1542200000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 112618798.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 120689655.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Basic EPS: -14.91
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: -2.32
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1829300000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 1593800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 1593800000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -5992600000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure Reported: -5992600000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 817100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 817100000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 120600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 120600000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 639900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 639900000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 702300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 702300000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 90200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 90200000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 549700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 549700000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 658600000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 127600000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -909000000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Change In Payable: -1344700000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 144300000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -1141700000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -1281400000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 120600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 120600000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 15636000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 15636000000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 4954900000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 25184300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 25184300000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 13835600000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3214000000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 7967600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 7967600000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 21700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 21700000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 5271600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 5271600000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 5293300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5293300000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 12973000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 12973000000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 80300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 80300000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Depreciation: 883600000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 883600000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 883600000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 212800000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 883600000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 212800000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 112618798.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 120689655.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Diluted EPS: -14.91
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: -2.32
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -1679100000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -280000000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 8700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 8700000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 22700000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — EBIT: -1212300000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — EBIT: -147900000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — EBITDA: -328700000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — EBITDA: 64900000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 92000000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 639900000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Financial Assets: 24500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets: 24500000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 6028700000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 353500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 353500000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -7299900000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -56300000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -900000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 197200000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 3300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 3300000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 2025000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 2025000000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 42539400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 42539400000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Gross Profit: 3383000000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1028500000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 24700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 24700000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Interest Expense: 805600000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 236000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 805600000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 236000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Interest Income: 44800000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 44800000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -1766000000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 17600000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Inventories Adjustments Allowances: -12600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -12600000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Inventory: 1846800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1846800000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 36566000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 36566000000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -6002800000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 1542200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1542200000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 4954900000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 13831100000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 726800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 726800000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 795400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 795400000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 15658400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 15658400000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 16453800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 16453800000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 13831100000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -10956100000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 108800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 108800000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 13732400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 13732400000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 0.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 4954900000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Net Debt: 20290100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 20290100000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 36300000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Net Income: -1679100000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Net Income: -280000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -1679100000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -280000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -1679100000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -280000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -1679100000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -280000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -1679100000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -280000000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -2017900000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -1679100000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -280000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -845200000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -236000000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 8900000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 2875000000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 2875000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -845200000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -236000000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -60500000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 37688100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 37688100000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 1100000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 15632700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 15632700000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 454300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 454300000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 268600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 268600000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 108800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 108800000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 139900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 139900000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: -306700000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 144700000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Normalized Income: -1660793741.02
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: -221797343.06
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -1307300000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Operating Income: -1069000000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Operating Income: -151100000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 17218600000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 4242500000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 120552774.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 120552774.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 1257300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1257300000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 8800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 8800000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 15515400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 15515400000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 3300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 3300000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 47500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 47500000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 831000000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 46900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 46900000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 454300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 454300000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 3300000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 83000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1754800000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 756500000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Other Payable: 4470800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 4470800000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 1302100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 1302100000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 64100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 64100000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 62400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 62400000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Other Special Charges: 73600000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Other Special Charges: 79800000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Payables: 7358000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 7358000000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 38000000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 80300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 80300000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 1417900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1417900000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Pretax Income: -2017900000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: -383900000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -3200000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 1126800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 1126800000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 13835600000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3214000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 883600000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 212800000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 93900000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 93900000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -10956100000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Research And Development: 19500000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 1941800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 1941800000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 5908600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 5908600000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 8900000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 1100000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 798000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 995200000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 120552774.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 120552774.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Special Income Charges: -73600000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -79800000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 15636000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 15636000000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 15632700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 15632700000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -3693741.02
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -21597343.06
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Tax Provision: -338800000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -103900000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.17
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.27
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 138700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 138700000.00
TIRUMALCHM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: 44000000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 47365600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 47365600000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 31294400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 31294400000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 21747100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 21747100000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 15636000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 15636000000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Total Expenses: 18287600000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 4393600000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 31729600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 31729600000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 39398000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 39398000000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 18756600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 18756600000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 84400000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 7800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 7800000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -22000000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -79800000.00
TIRUMALCHM.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -22000000.00
TIRUMALCHM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -79800000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Work In Process: 331600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 331600000.00
TIRUMALCHM.NS balance_sheet (annual, 2026-03-31) — Working Capital: -5005400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: -5005400000.00
TISI cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 64632000.00
TISI balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 83096000.00
TISI cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
TISI balance_sheet (annual, 2021-12-31) — Employee Benefits: 0.00
TISI cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 59000.00
TISI cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
TISI income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -59000.00
TISI balance_sheet (annual, 2021-12-31) — Goodwill: 25243000.00
TISI income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 55837000.00
TISI cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 5829000.00
TISI cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
TISI cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
TISI income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: -1174000.00
TISI cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 53000000.00
TISI balance_sheet (annual, 2021-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
TISI balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 16396000.00
TISI balance_sheet (annual, 2021-12-31) — Preferred Stock: 0.00
TISI cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
TISI balance_sheet (annual, 2021-12-31) — Restricted Cash: 4100000.00
TISI income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 2535000.00
TISI cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
TISI cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 190000000.00
TISI cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -137000000.00
TISI income_statement (annual, 2022-12-31) — +Operating Expense: 241397000.00
TISI income_statement (annual, 2022-12-31) — +Total Revenue: 840208000.00
TISI balance_sheet (annual, 2022-12-31) — Accounts Payable: 32524000.00
TISI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 160572000.00
TISI balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -293256000.00
TISI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 457133000.00
TISI cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 2748000.00
TISI balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 0.00
TISI income_statement (annual, 2022-12-31) — Basic Average Shares: 4187000.00
TISI income_statement (annual, 2022-12-31) — Basic EPS: -35.85
TISI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 65315000.00
TISI balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 50833000.00
TISI cash_flow (annual, 2022-12-31) — Capital Expenditure: -24690000.00
TISI cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -24690000.00
TISI balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 52642000.00
TISI balance_sheet (annual, 2022-12-31) — Capital Stock: 1303000.00
TISI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 58075000.00
TISI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 58075000.00
TISI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -191971000.00
TISI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 243356000.00
TISI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -57935000.00
TISI cash_flow (annual, 2022-12-31) — Change In Account Payable: -13291000.00
TISI cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 15195000.00
TISI cash_flow (annual, 2022-12-31) — Change In Inventory: -1655000.00
TISI cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 6264000.00
TISI cash_flow (annual, 2022-12-31) — Change In Payable: -13291000.00
TISI cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1904000.00
TISI cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -3201000.00
TISI cash_flow (annual, 2022-12-31) — Change In Receivables: -33483000.00
TISI cash_flow (annual, 2022-12-31) — Change In Working Capital: -30171000.00
TISI cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -33483000.00
TISI cash_flow (annual, 2022-12-31) — Changes In Cash: -6550000.00
TISI balance_sheet (annual, 2022-12-31) — Common Stock: 1303000.00
TISI balance_sheet (annual, 2022-12-31) — Common Stock Equity: 117760000.00
TISI cash_flow (annual, 2022-12-31) — Common Stock Issuance: 9639000.00
TISI balance_sheet (annual, 2022-12-31) — Construction In Progress: 19196000.00
TISI income_statement (annual, 2022-12-31) — Cost Of Revenue: 638597000.00
TISI balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 111919000.00
TISI balance_sheet (annual, 2022-12-31) — Current Assets: 347553000.00
TISI balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 13823000.00
TISI balance_sheet (annual, 2022-12-31) — Current Debt: 280993000.00
TISI balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 294816000.00
TISI balance_sheet (annual, 2022-12-31) — Current Liabilities: 448864000.00
TISI cash_flow (annual, 2022-12-31) — Deferred Income Tax: 653000.00
TISI cash_flow (annual, 2022-12-31) — Deferred Tax: 653000.00
TISI balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 398000.00
TISI cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 37595000.00
TISI cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 37595000.00
TISI income_statement (annual, 2022-12-31) — Diluted Average Shares: 4187000.00
TISI income_statement (annual, 2022-12-31) — Diluted EPS: -35.85
TISI income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 70079000.00
TISI income_statement (annual, 2022-12-31) — EBIT: -61729000.00
TISI income_statement (annual, 2022-12-31) — EBITDA: -24134000.00
TISI cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -690000.00
TISI cash_flow (annual, 2022-12-31) — End Cash Position: 58075000.00
TISI cash_flow (annual, 2022-12-31) — Financing Cash Flow: -191971000.00
TISI balance_sheet (annual, 2022-12-31) — Finished Goods: 24408000.00
TISI cash_flow (annual, 2022-12-31) — Free Cash Flow: -82625000.00
TISI cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -203351000.00
TISI balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -38997000.00
TISI balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 75407000.00
TISI balance_sheet (annual, 2022-12-31) — Gross PPE: 479817000.00
TISI income_statement (annual, 2022-12-31) — Gross Profit: 201611000.00
TISI income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
TISI balance_sheet (annual, 2022-12-31) — Income Tax Payable: 2257000.00
TISI income_statement (annual, 2022-12-31) — Interest Expense: 85052000.00
TISI income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 85052000.00
TISI cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 29187000.00
TISI balance_sheet (annual, 2022-12-31) — Interest Payable: 3963000.00
TISI balance_sheet (annual, 2022-12-31) — Inventory: 36331000.00
TISI balance_sheet (annual, 2022-12-31) — Invested Capital: 403695000.00
TISI cash_flow (annual, 2022-12-31) — Investing Cash Flow: 243356000.00
TISI cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 9639000.00
TISI cash_flow (annual, 2022-12-31) — Issuance Of Debt: 153938000.00
TISI balance_sheet (annual, 2022-12-31) — Land And Improvements: 4006000.00
TISI balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 38819000.00
TISI balance_sheet (annual, 2022-12-31) — Long Term Debt: 4942000.00
TISI balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 43761000.00
TISI cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 153938000.00
TISI cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -340968000.00
TISI balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 357320000.00
TISI cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 260841000.00
TISI cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 9639000.00
TISI balance_sheet (annual, 2022-12-31) — Net Debt: 227860000.00
TISI cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 1698000.00
TISI income_statement (annual, 2022-12-31) — Net Income: 70079000.00
TISI income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 70079000.00
TISI income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -150087000.00
TISI income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 220166000.00
TISI income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 70079000.00
TISI income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -150087000.00
TISI cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 70079000.00
TISI income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 70079000.00
TISI income_statement (annual, 2022-12-31) — Net Interest Income: -85052000.00
TISI cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -187030000.00
TISI cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -187030000.00
TISI income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -85052000.00
TISI cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -14580000.00
TISI cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 7205000.00
TISI balance_sheet (annual, 2022-12-31) — Net PPE: 186561000.00
TISI cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 2916000.00
TISI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 42353000.00
TISI balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 375000.00
TISI balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 3661000.00
TISI balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 375000.00
TISI balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 3661000.00
TISI income_statement (annual, 2022-12-31) — Normalized EBITDA: 5965000.00
TISI income_statement (annual, 2022-12-31) — Normalized Income: -120680277.00
TISI cash_flow (annual, 2022-12-31) — Operating Cash Flow: -57935000.00
TISI cash_flow (annual, 2022-12-31) — Operating Gains Losses: -188655000.00
TISI income_statement (annual, 2022-12-31) — Operating Income: -39786000.00
TISI income_statement (annual, 2022-12-31) — Operating Revenue: 840208000.00
TISI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 4342909.00
TISI balance_sheet (annual, 2022-12-31) — Other Current Assets: 11441000.00
TISI balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 280993000.00
TISI balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -38997000.00
TISI income_statement (annual, 2022-12-31) — Other Income Expense: -21943000.00
TISI balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 75407000.00
TISI cash_flow (annual, 2022-12-31) — Other Non Cash Items: 49167000.00
TISI balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 6351000.00
TISI balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 2599000.00
TISI income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 8156000.00
TISI balance_sheet (annual, 2022-12-31) — Other Properties: 48462000.00
TISI balance_sheet (annual, 2022-12-31) — Other Receivables: 70379000.00
TISI income_statement (annual, 2022-12-31) — Other Special Charges: 30083000.00
TISI balance_sheet (annual, 2022-12-31) — Payables: 42129000.00
TISI balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 154048000.00
TISI balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
TISI balance_sheet (annual, 2022-12-31) — Prepaid Assets: 15238000.00
TISI income_statement (annual, 2022-12-31) — Pretax Income: -146781000.00
TISI balance_sheet (annual, 2022-12-31) — Properties: 0.00
TISI cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 402000.00
TISI balance_sheet (annual, 2022-12-31) — Raw Materials: 8978000.00
TISI balance_sheet (annual, 2022-12-31) — Receivables: 226468000.00
TISI balance_sheet (annual, 2022-12-31) — Receivables Adjustments Allowances: -5262000.00
TISI income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 638597000.00
TISI income_statement (annual, 2022-12-31) — Reconciled Depreciation: 37595000.00
TISI cash_flow (annual, 2022-12-31) — Repayment Of Debt: -340968000.00
TISI income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 16000.00
TISI balance_sheet (annual, 2022-12-31) — Retained Earnings: -301679000.00
TISI cash_flow (annual, 2022-12-31) — Sale Of Business: 260841000.00
TISI income_statement (annual, 2022-12-31) — Selling General And Administration: 241397000.00
TISI balance_sheet (annual, 2022-12-31) — Share Issued: 4342909.00
TISI cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 118938000.00
TISI cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -116022000.00
TISI income_statement (annual, 2022-12-31) — Special Income Charges: -30099000.00
TISI cash_flow (annual, 2022-12-31) — Stock Based Compensation: 247000.00
TISI balance_sheet (annual, 2022-12-31) — Stockholders Equity: 117760000.00
TISI balance_sheet (annual, 2022-12-31) — Tangible Book Value: 42353000.00
TISI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -692277.00
TISI income_statement (annual, 2022-12-31) — Tax Provision: 3306000.00
TISI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.02
TISI balance_sheet (annual, 2022-12-31) — Taxes Receivable: 779000.00
TISI balance_sheet (annual, 2022-12-31) — Total Assets: 616645000.00
TISI balance_sheet (annual, 2022-12-31) — Total Capitalization: 122702000.00
TISI balance_sheet (annual, 2022-12-31) — Total Debt: 338577000.00